Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 8 | 2022 | 417 | 2.670 |
Why?
|
| Brenner Tumor | 3 | 2021 | 3 | 1.680 |
Why?
|
| Neoplasms, Complex and Mixed | 2 | 2020 | 5 | 1.220 |
Why?
|
| Ovary | 2 | 2021 | 379 | 1.170 |
Why?
|
| Fallopian Tube Neoplasms | 3 | 2022 | 14 | 1.020 |
Why?
|
| Uterine Neoplasms | 3 | 2022 | 106 | 1.010 |
Why?
|
| Carcinoma in Situ | 2 | 2022 | 71 | 0.950 |
Why?
|
| Immunohistochemistry | 8 | 2021 | 1690 | 0.930 |
Why?
|
| Biomarkers, Tumor | 10 | 2021 | 1474 | 0.920 |
Why?
|
| Endometrial Neoplasms | 4 | 2023 | 97 | 0.880 |
Why?
|
| Trophoblastic Neoplasms | 1 | 2022 | 5 | 0.810 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2022 | 9 | 0.810 |
Why?
|
| Gestational Trophoblastic Disease | 1 | 2022 | 7 | 0.810 |
Why?
|
| Pregnancy, Ectopic | 1 | 2022 | 23 | 0.790 |
Why?
|
| Appendiceal Neoplasms | 1 | 2022 | 17 | 0.790 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2022 | 35 | 0.790 |
Why?
|
| HIV Seropositivity | 1 | 2023 | 121 | 0.780 |
Why?
|
| Herpesviridae Infections | 1 | 2023 | 142 | 0.770 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 10 | 0.710 |
Why?
|
| Granulosa Cell Tumor | 1 | 2020 | 40 | 0.690 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2017 | 53 | 0.660 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2021 | 38 | 0.650 |
Why?
|
| Cell Lineage | 1 | 2021 | 338 | 0.640 |
Why?
|
| Endometrial Stromal Tumors | 1 | 2018 | 1 | 0.590 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2016 | 6 | 0.520 |
Why?
|
| PAX8 Transcription Factor | 4 | 2016 | 14 | 0.500 |
Why?
|
| Endometriosis | 4 | 2024 | 177 | 0.500 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2014 | 5 | 0.480 |
Why?
|
| Endometrium | 5 | 2024 | 281 | 0.450 |
Why?
|
| Sarcoma, Endometrial Stromal | 1 | 2013 | 1 | 0.440 |
Why?
|
| Female | 28 | 2025 | 66250 | 0.380 |
Why?
|
| Middle Aged | 13 | 2023 | 26583 | 0.370 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2011 | 3 | 0.370 |
Why?
|
| Neoplasms | 2 | 2023 | 2762 | 0.370 |
Why?
|
| Salpingo-oophorectomy | 3 | 2021 | 10 | 0.360 |
Why?
|
| Alphapapillomavirus | 1 | 2011 | 30 | 0.350 |
Why?
|
| Uterus | 3 | 2024 | 569 | 0.350 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 662 | 0.320 |
Why?
|
| Diagnosis, Differential | 4 | 2022 | 1879 | 0.320 |
Why?
|
| Biopsy | 4 | 2021 | 1238 | 0.280 |
Why?
|
| Fallopian Tubes | 3 | 2024 | 73 | 0.280 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 291 | 0.270 |
Why?
|
| Aged | 9 | 2022 | 19526 | 0.270 |
Why?
|
| Epithelium | 3 | 2023 | 362 | 0.270 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 487 | 0.260 |
Why?
|
| Humans | 28 | 2024 | 124122 | 0.260 |
Why?
|
| Adult | 11 | 2022 | 29322 | 0.260 |
Why?
|
| Autophagy-Related Proteins | 1 | 2025 | 34 | 0.240 |
Why?
|
| Pyroptosis | 1 | 2025 | 26 | 0.240 |
Why?
|
| PAX2 Transcription Factor | 2 | 2014 | 27 | 0.240 |
Why?
|
| GATA3 Transcription Factor | 2 | 2014 | 35 | 0.230 |
Why?
|
| Paired Box Transcription Factors | 2 | 2014 | 73 | 0.230 |
Why?
|
| Aminopyridines | 1 | 2024 | 55 | 0.220 |
Why?
|
| Embryo Implantation | 2 | 2024 | 233 | 0.210 |
Why?
|
| Smad Proteins | 1 | 2023 | 44 | 0.210 |
Why?
|
| Proteogenomics | 1 | 2023 | 67 | 0.200 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2022 | 24 | 0.200 |
Why?
|
| Epithelioid Cells | 1 | 2022 | 11 | 0.200 |
Why?
|
| Pyrroles | 1 | 2024 | 177 | 0.200 |
Why?
|
| Mucins | 1 | 2022 | 74 | 0.200 |
Why?
|
| Mucous Membrane | 1 | 2022 | 88 | 0.200 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 2139 | 0.200 |
Why?
|
| Hysterectomy | 2 | 2021 | 192 | 0.190 |
Why?
|
| Neoplasm Grading | 3 | 2021 | 272 | 0.190 |
Why?
|
| Metformin | 1 | 2023 | 149 | 0.190 |
Why?
|
| Pathologists | 1 | 2021 | 29 | 0.190 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 1 | 2021 | 5 | 0.180 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.180 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 126 | 0.170 |
Why?
|
| Infertility, Female | 1 | 2021 | 145 | 0.170 |
Why?
|
| Metaplasia | 1 | 2021 | 213 | 0.170 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 210 | 0.170 |
Why?
|
| Carcinoma, Endometrioid | 2 | 2016 | 15 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 530 | 0.170 |
Why?
|
| Progesterone | 2 | 2024 | 624 | 0.160 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 244 | 0.160 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 251 | 0.160 |
Why?
|
| Squamous Intraepithelial Lesions of the Cervix | 1 | 2018 | 2 | 0.160 |
Why?
|
| Smad2 Protein | 1 | 2019 | 49 | 0.160 |
Why?
|
| Human Papillomavirus DNA Tests | 1 | 2018 | 7 | 0.160 |
Why?
|
| Smad3 Protein | 1 | 2019 | 55 | 0.150 |
Why?
|
| Papanicolaou Test | 1 | 2018 | 33 | 0.150 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 794 | 0.150 |
Why?
|
| Gastric Mucosa | 1 | 2021 | 484 | 0.150 |
Why?
|
| Gastritis | 1 | 2021 | 371 | 0.150 |
Why?
|
| Infertility | 1 | 2019 | 76 | 0.150 |
Why?
|
| Pregnancy | 4 | 2025 | 7164 | 0.140 |
Why?
|
| Proteomics | 1 | 2021 | 496 | 0.140 |
Why?
|
| Peritoneum | 1 | 2017 | 36 | 0.140 |
Why?
|
| Omentum | 1 | 2017 | 47 | 0.140 |
Why?
|
| Electrosurgery | 1 | 2017 | 17 | 0.140 |
Why?
|
| Neoplasm Staging | 3 | 2021 | 1233 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 641 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2017 | 83 | 0.130 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2017 | 29 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 338 | 0.130 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 6465 | 0.130 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2016 | 32 | 0.130 |
Why?
|
| Vulvar Neoplasms | 1 | 2016 | 18 | 0.130 |
Why?
|
| Dermatofibrosarcoma | 1 | 2016 | 17 | 0.130 |
Why?
|
| Adnexal Diseases | 1 | 2016 | 23 | 0.130 |
Why?
|
| Adenoma | 1 | 2016 | 129 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2014 | 2586 | 0.120 |
Why?
|
| Staining and Labeling | 1 | 2014 | 186 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 544 | 0.110 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 1888 | 0.110 |
Why?
|
| Retrospective Studies | 4 | 2021 | 16264 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2013 | 229 | 0.100 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2011 | 7 | 0.100 |
Why?
|
| Keratins | 1 | 2011 | 55 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1889 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 611 | 0.090 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2011 | 19 | 0.090 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2011 | 58 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 100 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2011 | 73 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 470 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2011 | 355 | 0.080 |
Why?
|
| Animals | 6 | 2025 | 34002 | 0.080 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 160 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2024 | 3718 | 0.080 |
Why?
|
| DNA, Viral | 1 | 2011 | 480 | 0.080 |
Why?
|
| Mutation | 2 | 2020 | 5827 | 0.080 |
Why?
|
| Mice | 5 | 2025 | 17582 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 809 | 0.080 |
Why?
|
| RNA, Viral | 1 | 2011 | 540 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 668 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 723 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2011 | 817 | 0.060 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2024 | 28 | 0.060 |
Why?
|
| Oviducts | 1 | 2025 | 338 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 20 | 0.060 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 29 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2024 | 127 | 0.050 |
Why?
|
| Time Factors | 1 | 2013 | 6279 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 125 | 0.050 |
Why?
|
| Embryo, Mammalian | 1 | 2025 | 453 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 4334 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 204 | 0.050 |
Why?
|
| Autophagy | 1 | 2025 | 387 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 801 | 0.050 |
Why?
|
| Activin Receptors, Type II | 1 | 2021 | 31 | 0.050 |
Why?
|
| Smad5 Protein | 1 | 2021 | 22 | 0.050 |
Why?
|
| Smad1 Protein | 1 | 2021 | 22 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2019 | 2285 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2021 | 41 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 481 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 833 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 286 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2024 | 4498 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 4778 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 202 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 403 | 0.040 |
Why?
|
| Homeostasis | 1 | 2023 | 685 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 1596 | 0.040 |
Why?
|
| Estrogens | 1 | 2021 | 514 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2024 | 2390 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2023 | 6117 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12275 | 0.040 |
Why?
|
| Role | 1 | 2017 | 24 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2017 | 45 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 42 | 0.030 |
Why?
|
| Young Adult | 1 | 2011 | 8983 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 51 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 68 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 231 | 0.030 |
Why?
|
| Medicare | 1 | 2020 | 423 | 0.030 |
Why?
|
| DNA Mismatch Repair | 1 | 2016 | 49 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 158 | 0.030 |
Why?
|
| Sertoli Cell Tumor | 1 | 2016 | 8 | 0.030 |
Why?
|
| Neurofibroma | 1 | 2016 | 6 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 117 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2019 | 332 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 502 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1172 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 2035 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 1100 | 0.030 |
Why?
|
| Antibodies | 1 | 2016 | 372 | 0.030 |
Why?
|
| Receptors, Progesterone | 1 | 2019 | 878 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 946 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 663 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1328 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1282 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2087 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 332 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2047 | 0.020 |
Why?
|
| Male | 2 | 2021 | 60978 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2017 | 2816 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 299 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 1135 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1699 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2517 | 0.020 |
Why?
|
| Prognosis | 1 | 2017 | 4608 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2862 | 0.010 |
Why?
|
| United States | 1 | 2020 | 10856 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 2495 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10241 | 0.010 |
Why?
|